Researchers have identified a critical weakness in drug resistant bacteria by disrupting the protein folding processes required for their survival, a breakthrough that could restore the effectiveness of existing antibiotics. The findings focus on disabling the mechanisms bacteria use to build resistance......
New research is reshaping expectations for one of the deadliest cancers. Scientists report that personalized mRNA vaccines can trigger sustained immune responses in patients with pancreatic cancer, with some surviving at least six years after treatment. The findings come as advances in immunology and......
Researchers have identified a strong link between gut bacteria composition and the risk of melanoma returning after treatment, offering a new tool to guide clinical decisions before therapy begins. The findings show that specific microbial profiles in the intestine can predict cancer recurrence with......
The United States has announced an expanded financial commitment, in partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria, to scale up access to a new preventive HIV treatment across several low-income countries, including Morocco. The initiative aims to significantly increase the......
A new study suggests a simple blood test can predict the progression of Alzheimer’s disease years before changes appear on brain scans. Researchers at Mass General Brigham reported the findings in Nature Communications, marking a significant step toward earlier detection of the disease. The study......
Revolution Medicines announced Monday that its oral anticancer drug daraxonrasib almost doubled overall survival for patients with previously treated metastatic pancreatic cancer compared to standard intravenous chemotherapy. The results sent the company's stock up more than 30 percent in premarket......
The acting director of the U.S. Centers for Disease Control and Prevention (CDC) has postponed the release of a report demonstrating that COVID-19 vaccines reduced emergency department visits and hospitalizations for healthy adults during the previous winter by approximately 50%, according to the Washington......
Shares of major U.S. health insurers surged in premarket trading on Tuesday following the announcement of higher-than-expected payment rates for Medicare Advantage plans in 2027. UnitedHealth led the gains with a 6.9% increase, while CVS Health, Elevance Health, Centene, and Molina Healthcare rose between......
The Eli Lilly and Co weight-loss pill has received approval from the U.S. Food and Drug Administration, marking a major step in the growing market for oral obesity treatments. The drug, called orforglipron and marketed under the brand name Foundayo, becomes the second pill-based option available in the......
A wave of new research is transforming scientific understanding of cancer at its most fundamental level. Several studies published in recent weeks show that the physical behavior of DNA and the internal mechanics of cells play a far greater role in cancer development and spread than previously understood,......
Pfizer and Valneva said their experimental Lyme disease vaccine achieved more than 70 percent efficacy in a large phase 3 clinical trial, marking a significant step toward the first approved human vaccine for the disease in more than two decades. Results from the VALOR trial showed the vaccine was 73.2......
Avian influenza cases are rising across multiple regions as migratory birds begin their annual spring movement, triggering mass culling operations and tighter biosecurity measures in North America, Europe and Asia. In the United States, more than 14.3 million birds across 84 farms have been infected......
Eli Lilly said its experimental drug retatrutide met all primary and secondary endpoints in a phase 3 clinical trial for type 2 diabetes, delivering significant reductions in blood sugar and body weight over 40 weeks. The TRANSCEND-T2D-1 trial involved 537 adults whose diabetes was not adequately controlled......
-
08:15
-
16:45
-
15:45
-
13:15
-
12:20
-
12:00
-
11:20
-
11:00
-
10:40
-
10:20
-
10:00
-
09:00
